跳至主要内容
临床试验/NL-OMON40371
NL-OMON40371已完成不适用

Targeting Antibiotics to Pseudomonas Aeruginosa in Small airways (TAPAS) study in patients with cystic fibrosis: pharmacokinetics (PK) - TAPAS-PK study in patients with CF

HagaZiekenhuis0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Age * 18 years;
  • * FEV1 predicted * 30%;
  • * Clinical diagnosis of CF and a positive sweat test or two CF-related mutations;
  • * Chronic PA colonization requiring;
  • * Ability to breathe through a mouthpiece and to use the inhaler;
  • * Ability to perform lung function tests;
  • * Written informed consent.

排除标准

  • * Severe acute exacerbation of pulmonary infection (needing intravenous treatment);
  • * Patients receiving intravenous tobramycin treatment;
  • * Patients who are pregnant, planning to become pregnant or breastfeeding;
  • * Known impaired kidney function (estimated creatinine clearance < 60 ml/min);
  • * Known aminoglycoside hypersensitivity;
  • * Therapy (e.g. furosemide) or disease which may complicate evaluation of the study protocol, as judged by the investigator;
  • * Participation in another drug-investigating clinical study at the start or within 1 month prior to the start;
  • * Inability to follow instructions of the investigator.

研究者

相似试验